Clinical data | |
---|---|
Trade names | Hexobarbital, Hexobarbitone, Methylhexabital, Methexenyl, Evipal |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Protein binding | 25% |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.241 |
Chemical and physical data | |
Formula | C12H16N2O3 |
Molar mass | 236.271 g·mol−1 |
3D model (JSmol) | |
Chirality | Racemic mixture |
Density | 1.1623 g/cm3 |
Melting point | 146.5 °C (295.7 °F) |
Boiling point | 378.73 °C (713.71 °F) |
Solubility in water | 0.435 mg/mL (20 °C) |
| |
| |
(verify) |
Hexobarbital or hexobarbitone, sold both in acid and sodium salt forms as Citopan, Evipan, and Tobinal, is a barbiturate derivative having hypnotic and sedative effects. It was used in the 1940s and 1950s as an agent for inducing anesthesia for surgery, as well as a rapid-acting, short-lasting hypnotic for general use, and has a relatively fast onset of effects and short duration of action.[1] Modern barbiturates (such as Thiopental) have largely supplanted the use of hexobarbital as an anesthetic, as they allow for better control of the depth of anesthesia.[2] Hexobarbital is still used in some scientific research.[3]